We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Stem Cell Therapeutics Corp. Announces the Issuance of United States Patent Relating to NTx®-265

News   Dec 09, 2010

 
Stem Cell Therapeutics Corp. Announces the Issuance of United States Patent Relating to NTx®-265
 
 
 

RELATED ARTICLES

Novel Therapeutic Approach to Treat Osteoarthritis

News

Researchers from Texas A&M University, led by Dr. Akhilesh K. Gaharwar, have developed a new way to deliver treatment for cartilage regeneration.

READ MORE

Engineered "Suicide Genes" Safely Grow Beta Cells From Stem Cells

News

A human pluripotent stem cell line has been engineered which contains two ‘suicide genes’ that induce cell death in all but the desired insulin-producing cells. This double fail-safe approach opens the door to creating safe cell-replacement therapies for people living with type 1 diabetes.

READ MORE

Lung Therapy Targets Derived From Fetal Signaling Pathways

News

Specialized lung cells appear in the developing fetus much earlier than scientists previously thought.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE